Stealth BioTherapeutics Company
Stealth is a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving mitochondrial dysfunction. Mitochondria, found in nearly every cell in the body, are the body's main source of energy production and are critical for normal organ function.
Investors
Total Funding:
$120M
Headquarters:
Cayman Islands
Funding Status:
IPO
Employee Number:
101-250
Estimated Revenue:
$10M to $50M
Last Funding Type:
Post-IPO Equity
Number Of Exists:
Post-IPO Equity
Technology:
Geroscience
Investor Type:
Company
Investors Number:
8
Founded Date:
2007
Industry:
Oxidative Phosphorylation